MannKind | MNKD - Créanciers Commerciaux





Créanciers Commerciaux Changement Date
Adma Biologics USD 22.52M 1.5M 2025-12
BioCryst Pharmaceuticals USD 15.83M 10.26M 2025-12
Eli Lilly USD 5.38B 1.12B 2025-12
Halozyme Therapeutics USD 20.9M 5.54M 2025-12
Insmed USD 79.91M 316K 2025-12
Karyopharm Therapeutics USD 5.39M 2.8M 2025-09
MacroGenics USD 4.79M 1.15M 2025-12
MannKind USD 9.03M 1.76M 2025-12
Merck USD 4.15B 102M 2025-09
Minerva Neurosciences USD 640K 305K 2025-12
Novavax USD 24.58M 9.35M 2025-12
Novo Nordisk DKK 4.46B 15.12B 2025-06
Pfizer USD 5.02B 142M 2025-09
Sanofi EUR 22.93B 927M 2025-12
Xencor USD 10.83M 1.75M 2025-12